Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
496.3 INR | -1.08% | -2.32% | +49.80% |
Apr. 18 | Shilpa Medicare Partner Amneal Pharma Launches Ready-to-Use Pemetrexed in US | MT |
Apr. 17 | Shilpa Medicare Gets GMP Certification from Austrian Agency for Telangana, India Unit | MT |
- Stock Market
- Equities
- SHILPAMED Stock
- News Shilpa Medicare Limited
- MarketScreener Strategies